Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Why we need to curb the emerging worldwide epidemic of nonalcoholic fatty liver disease

Nature Metabolism volume 1, pages 1027–1029 (2019)Cite this article

Subjects

Nonalcoholic fatty liver disease (NAFLD) has emerged as the most prevalent liver disease worldwide, mainly because of the massive parallel global increase in obesity. Extensive public-health and political efforts will be needed in the near future to counteract this disturbing development.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Estes, C. et al. J. Hepatol. 69, 896–904 (2018).

    Article  Google Scholar 

  2. Haldar, D. et al. J. Hepatol. 71, 313–322 (2019).

    Article  Google Scholar 

  3. Li, Z. et al. J. Gastroenterol. Hepatol. 29, 42–51 (2014).

    Article  CAS  Google Scholar 

  4. Stepanova, M. et al. Clin Gastroenterol Hepatol 15, 759–766.e755 (2017).

    Article  Google Scholar 

  5. Jewell, J. & Sheron, N. Clin. Med. (Lond.) 10, 259–263 (2010).

    Article  Google Scholar 

  6. Clair, H. B. et al. Toxicol. Sci. 164, 39–49 (2018).

    Article  CAS  Google Scholar 

  7. Ryan, D. H. & Yockey, S. R. Curr. Obes. Rep. 6, 187–194 (2017).

    Article  Google Scholar 

  8. Tremmel, M., Gerdtham, U. G., Nilsson, P. M. & Saha, S. Int. J. Environ. Res. Public Health 14, 435 (2017).

    Article  Google Scholar 

  9. Brewis, A. A. Soc. Sci. Med. 118, 152–158 (2014).

    Article  Google Scholar 

  10. Bilger, M., Kruger, E. J. & Finkelstein, E. A. Health Econ. 26, 1052–1066 (2017).

    Article  Google Scholar 

  11. Lazarus, J. V. et al. J. Hepatol. https://doi.org/10.1016/j.jhep.2019.08.027 (2019).

  12. Barata Cavalcanti, O. World Obesity https://s3-eu-west-1.amazonaws.com/wof-files/LATAM_presentation_Regional_Dialogue__Barata_cavalcanti_FINAL.pdf (2019).

  13. Williams, R. et al. Lancet 392, 2398–2412 (2018).

    Article  Google Scholar 

  14. European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD) & European Association for the Study of Obesity (EASO). J. Hepatol. 64, 1388–1402 (2016).

  15. Ananthapavan, J., Sacks, G., Moodie, M. & Carter, R. Int. J. Environ. Res. Public Health 11, 4007–4025 (2014).

    Article  Google Scholar 

  16. Williams, R. et al. Lancet 384, 1953–1997 (2014).

    Article  Google Scholar 

  17. Anderson, E. L. et al. PLoS One 10, e0140908 (2015).

    Article  Google Scholar 

  18. O’Reilly, J. R. & Reynolds, R. M. Clin. Endocrinol. 78, 9–16 (2013).

    Article  Google Scholar 

  19. Wesolowski, S. R., Kasmi, K. C., Jonscher, K. R. & Friedman, J. E. Nat. Rev. Gastroenterol. Hepatol. 14, 81–96 (2017).

    Article  CAS  Google Scholar 

  20. Skouteris, H. et al. Front. Endocrinol. (Lausanne) 10, 163 (2019).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Duke University, Durham, NC, USA

    Anna Mae Diehl

  2. Obesity Prevention and Care Program “Contrepoids”, Service of Therapeutic Education for Chronic Diseases, Department of Primary Care, University Hospitals of Geneva, Geneva, Switzerland

    Nathalie J. Farpour-Lambert

  3. Department of Biochemistry and Microbiology, Institute of Food, Nutrition and Health, Rutgers University, Newark, NJ, USA

    Liping Zhao

  4. State Key Laboratory for Microbial Metabolism, Shanghai Jiao Tong University, Shanghai, China

    Liping Zhao

  5. Department of Internal Medicine I, Gastroenterology, Hepatology, Metabolism & Endocrinology, Innsbruck, Austria

    Herbert Tilg

Authors
  1. Anna Mae Diehl
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nathalie J. Farpour-Lambert
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Liping Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Herbert Tilg
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors researched data for this article, and wrote, reviewed and edited the manuscript.

Corresponding authors

Correspondence to Anna Mae Diehl or Herbert Tilg.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Diehl, A.M., Farpour-Lambert, N.J., Zhao, L. et al. Why we need to curb the emerging worldwide epidemic of nonalcoholic fatty liver disease. Nat Metab 1, 1027–1029 (2019). https://doi.org/10.1038/s42255-019-0140-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s42255-019-0140-x

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing